Literature DB >> 15813727

Defining the role of PfCRT in Plasmodium falciparum chloroquine resistance.

Patrick G Bray1, Rowena E Martin, Leann Tilley, Stephen A Ward, Kiaran Kirk, David A Fidock.   

Abstract

Recent studies have highlighted the importance of a parasite protein referred to as the chloroquine resistance transporter (PfCRT) in the molecular basis of Plasmodium falciparum resistance to the quinoline antimalarials. PfCRT, an integral membrane protein with 10 predicted transmembrane domains, is a member of the drug/metabolite transporter superfamily and is located on the membrane of the intra-erythrocytic parasite's digestive vacuole. Specific polymorphisms in PfCRT are tightly correlated with chloroquine resistance. Transfection studies have now proven that pfcrt mutations confer verapamil-reversible chloroquine resistance in vitro and reveal their important role in resistance to quinine. Available evidence is consistent with the view that PfCRT functions as a transporter directly mediating the efflux of chloroquine from the digestive vacuole.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15813727     DOI: 10.1111/j.1365-2958.2005.04556.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  58 in total

Review 1.  Know your enemy: understanding the role of PfCRT in drug resistance could lead to new antimalarial tactics.

Authors:  Robert L Summers; Megan N Nash; Rowena E Martin
Journal:  Cell Mol Life Sci       Date:  2012-06       Impact factor: 9.261

Review 2.  Transporters involved in resistance to antimalarial drugs.

Authors:  Stephanie G Valderramos; David A Fidock
Journal:  Trends Pharmacol Sci       Date:  2006-09-25       Impact factor: 14.819

3.  Discovery of novel inhibitors targeting enoyl-acyl carrier protein reductase in Plasmodium falciparum by structure-based virtual screening.

Authors:  George Nicola; Colin A Smith; Edinson Lucumi; Mack R Kuo; Luchezar Karagyozov; David A Fidock; James C Sacchettini; Ruben Abagyan
Journal:  Biochem Biophys Res Commun       Date:  2007-04-26       Impact factor: 3.575

4.  Synthesis and antimalarial activity of new 4-amino-7-chloroquinolyl amides, sulfonamides, ureas and thioureas.

Authors:  Kekeli Ekoue-Kovi; Kimberly Yearick; Daniel P Iwaniuk; Jayakumar K Natarajan; John Alumasa; Angel C de Dios; Paul D Roepe; Christian Wolf
Journal:  Bioorg Med Chem       Date:  2008-11-12       Impact factor: 3.641

5.  Linkage disequilibrium between two distinct loci in chromosomes 5 and 7 of Plasmodium falciparum and in vivo chloroquine resistance in Southwest Nigeria.

Authors:  C T Happi; G O Gbotosho; O A Folarin; A Sowunmi; O M Bolaji; B A Fateye; D E Kyle; W Milhous; D F Wirth; A M J Oduola
Journal:  Parasitol Res       Date:  2006-07-28       Impact factor: 2.289

6.  Differential drug efflux or accumulation does not explain variation in the chloroquine response of Plasmodium falciparum strains expressing the same isoform of mutant PfCRT.

Authors:  Adele M Lehane; Donelly A van Schalkwyk; Stephanie G Valderramos; David A Fidock; Kiaran Kirk
Journal:  Antimicrob Agents Chemother       Date:  2011-02-22       Impact factor: 5.191

7.  Chloroquine resistance-conferring mutations in pfcrt give rise to a chloroquine-associated H+ leak from the malaria parasite's digestive vacuole.

Authors:  Adele M Lehane; Kiaran Kirk
Journal:  Antimicrob Agents Chemother       Date:  2008-10-13       Impact factor: 5.191

8.  Overcoming Chloroquine Resistance in Malaria: Design, Synthesis, and Structure-Activity Relationships of Novel Hybrid Compounds.

Authors:  Aicha Boudhar; Xiao Wei Ng; Chiew Yee Loh; Wan Ni Chia; Zhi Ming Tan; Francois Nosten; Brian W Dymock; Kevin S W Tan
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

Review 9.  Drug-resistant malaria - an insight.

Authors:  John E Hyde
Journal:  FEBS J       Date:  2007-09       Impact factor: 5.542

10.  On the mechanism of chloroquine resistance in Plasmodium falciparum.

Authors:  Mauro Chinappi; Allegra Via; Paolo Marcatili; Anna Tramontano
Journal:  PLoS One       Date:  2010-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.